Bafna Mahaveer Chand receives National Level SME & Entrepreneurship Excellence award

Award recognizes the exceptional achievements by Bafna Pharma in the pharmaceutical industry in domestic and global markets

Bafna Pharmaceuticals, (BSE Code: 532989) Chennai-based pharma company engaged in the business of manufacturing of pharmaceutical formulations of Betalactum and Non–Betalactum adds yet another recognition to its kitty. Mr. Bafna Mahaveer Chand, Chairman & Managing Director, Bafna Pharma has been conferred with the National Level Entrepreneurship Excellence Award in the manufacturing sector from Small & Medium Business Development Chamber of India (SME Chamber of India). The award was received by Mr. Bafna at the hands of Mr. C.B. Bhave, Chairman, SEBI in a glitterati event in Mumbai yesterday. In January 2010 Bafna Pharmaceuticals was honored with the Gold Quality Excellence award by IDMA (Indian Drug Manufacturers’ Association).

Organised by Small & Medium Business Development Chamber of India (SME Chamber of India) and India International Trade Centre (IITC-INDIA), the award recognize micro, small and medium enterprises for their exceptional achievements in their respective fields.

Accepting the award, an elated Mr. Bafna Mahaveer Chand, Chairman and MD of Bafna Pharmaceuticals Ltd. expressed, “The National Level SME & Entrepreneurship Excellence award provides us the opportunity to celebrate the progress of our sector and the company. This award is the recognition of Bafna Pharma’s prosperous growth in recent times. This recognition will help us to enhance the confidence of our investors, customers and last but not the least our employees in the internal functioning of the Company. It further reinforces our vision to become the leading professionally run global pharma company setting standards across the pharma value chain.”

Small & Medium Business Development Chamber of India (SME Chamber of India) and India International Trade Centre (IITC-INDIA) are leading organisations working for the development of the MSME sector and organize various trade promotional activities in India and abroad for many years.

About Bafna Pharmaceuticals Ltd:
The company has over 77 products registered in Sri Lanka, Ukarine, Lao and Ghana. The company has two manufacturing facilities. A WHO-GMP certified manufacturing facility in Madhavaram, which is a 100 percent Export oriented Unit (EOU) and an EU GMP facility at Grantlayan, Chennai. Recently the company received the Good Manufacturing Practices (GMP) approval from Ethiopia’s Drug Administration and Control Authority (DACA) for its non-betalactam facility.

The company in the month of April 2010 inaugurated its Research and Development (Formulation) (FR&D) facility, a pilot plant in Chennai. The company has secured ISO 9001: 2008 Certificate of Registration for Manufacture and Export of Pharmaceutical products. Bafna Pharma has also received EU GMP Compliances from (MHRA) Medicines and Healthcare products Regulatory Agency, U.K. This accreditation has made Bafna Pharmaceuticals the 35th facility to achieve this key recognition in India and has opened the gates for exploring markets of European Union.